Almitas Capital LLC Rallybio Corp Transaction History
Almitas Capital LLC
- $205 Million
- Q4 2024
A detailed history of Almitas Capital LLC transactions in Rallybio Corp stock. As of the latest transaction made, Almitas Capital LLC holds 1,298,119 shares of RLYB stock, worth $830,796. This represents 0.61% of its overall portfolio holdings.
Number of Shares
1,298,119
Previous 875,434
48.28%
Holding current value
$830,796
Previous $1.02 Million
21.68%
% of portfolio
0.61%
Previous 0.48%
Shares
3 transactions
Others Institutions Holding RLYB
# of Institutions
50Shares Held
32.9MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$2.68 Million0.01% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.64MShares$2.33 Million1.19% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$2.32 Million1.55% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$2.11 Million4.27% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$1.94 Million0.08% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $20.6M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...